Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1412, Issue 1, Pages 154-165
Publisher
Wiley
Online
2018-01-31
DOI
10.1111/nyas.13535
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients
- (2017) Inga Koneczny et al. JOURNAL OF AUTOIMMUNITY
- Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep Sequencing
- (2017) Jason A. Vander Heiden et al. JOURNAL OF IMMUNOLOGY
- High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease
- (2017) Bishnudeo Roy et al. JOURNAL OF IMMUNOLOGY
- First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
- (2017) Pascal Joly et al. LANCET
- Pemphigus
- (2017) Michael Kasperkiewicz et al. Nature Reviews Disease Primers
- Roles of collagen Q in MuSK antibody-positive myasthenia gravis
- (2016) Kinji Ohno et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Distinctions among Circulating Antibody-Secreting Cell Populations, Including B-1 Cells, in Human Adult Peripheral Blood
- (2016) Tâm D. Quách et al. JOURNAL OF IMMUNOLOGY
- Myasthenia Gravis
- (2016) Nils E. Gilhus NEW ENGLAND JOURNAL OF MEDICINE
- Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cells
- (2016) Florian Rubelt et al. Nature Communications
- Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
- (2016) Jae-Yun Lee et al. Annals of Clinical and Translational Neurology
- Rituximab does not reset defective early B cell tolerance checkpoints
- (2015) Nicolas Chamberlain et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy
- (2015) P. Ruggenenti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- IgG4-related disease
- (2015) Terumi Kamisawa et al. LANCET
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus
- (2015) Christopher M Tipton et al. NATURE IMMUNOLOGY
- Selective response to rituximab in a young child with MuSK-associated myasthenia gravis
- (2015) Raghav Govindarajan et al. NEUROMUSCULAR DISORDERS
- Long-Term Remissions in Recalcitrant Pemphigus Vulgaris
- (2015) A. Razzaque Ahmed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations
- (2014) Zachary S Wallace et al. ANNALS OF THE RHEUMATIC DISEASES
- B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease
- (2014) Emanuel Della-Torre et al. ANNALS OF THE RHEUMATIC DISEASES
- De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease
- (2014) Hamid Mattoo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis
- (2014) A. Palanichamy et al. Science Translational Medicine
- Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis
- (2013) Lucas J. Maillette de Buy Wenniger et al. HEPATOLOGY
- Specific peripheral B cell tolerance defects in patients with multiple sclerosis
- (2013) Tuure Kinnunen et al. JOURNAL OF CLINICAL INVESTIGATION
- Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients
- (2013) Russell P. Hall et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients
- (2013) Siegfried Kohler et al. JOURNAL OF NEUROIMMUNOLOGY
- Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis
- (2013) Valentina Catzola et al. JOURNAL OF NEUROLOGY
- Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients: Table 1
- (2013) Benison Keung et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Prolonged B-Cell Depletion in MuSK Myasthenia Gravis Following Rituximab Treatment
- (2013) John S. Yi et al. MUSCLE & NERVE
- MuSK Myasthenia Gravis IgG4 Disrupts the Interaction of LRP4 with MuSK but Both IgG4 and IgG1-3 Can Disperse Preformed Agrin-Independent AChR Clusters
- (2013) Inga Koneczny et al. PLoS One
- Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
- (2013) N. Colliou et al. Science Translational Medicine
- Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
- (2012) Rinse Klooster et al. BRAIN
- Passive and active immunization models of MuSK-Ab positive myasthenia: Electrophysiological evidence for pre and postsynaptic defects
- (2012) Stuart Viegas et al. EXPERIMENTAL NEUROLOGY
- Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy
- (2012) Aisha V. Sauer et al. JOURNAL OF CLINICAL INVESTIGATION
- Consensus statement on the pathology of IgG4-related disease
- (2012) Vikram Deshpande et al. MODERN PATHOLOGY
- Long-lasting treatment effect of rituximab in MuSK myasthenia
- (2012) J. Diaz-Manera et al. NEUROLOGY
- A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
- (2011) M. Scully et al. BLOOD
- Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
- (2011) Antoine Froissart et al. CRITICAL CARE MEDICINE
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy
- (2011) L. H. Beck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts
- (2011) Jeffrey T. Guptill et al. MUSCLE & NERVE
- Response of patients with refractory myasthenia gravis to rituximab: a retrospective study
- (2011) Richard J. Nowak et al. Therapeutic Advances in Neurological Disorders
- Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis
- (2010) Osamu Higuchi et al. ANNALS OF NEUROLOGY
- Use and monitoring of low dose rituximab in myasthenia gravis
- (2010) S. Blum et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome
- (2010) P. Maddison et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Intrathecal pathogenic antiâaquaporin-4 antibodies in early neuromyelitis optica
- (2009) Jeffrey L. Bennett et al. ANNALS OF NEUROLOGY
- ELISA Testing of Anti–Desmoglein 1 and 3 Antibodies in the Management of Pemphigus
- (2009) Claire Abasq et al. ARCHIVES OF DERMATOLOGY
- Rituximab in the management of refractory myasthenia gravis
- (2009) Nazlee Zebardast et al. MUSCLE & NERVE
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire
- (2009) J. Glanville et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- B-cell tolerance checkpoints in health and autoimmunity
- (2008) Eric Meffre et al. CURRENT OPINION IN IMMUNOLOGY
- Successful treatment of refractory generalized myasthenia gravis with rituximab
- (2008) C. Lebrun et al. EUROPEAN JOURNAL OF NEUROLOGY
- IRAK-4- and MyD88-Dependent Pathways Are Essential for the Removal of Developing Autoreactive B Cells in Humans
- (2008) Isabelle Isnardi et al. IMMUNITY
- Rituximab Exerts a Dual Effect in Pemphigus Vulgaris
- (2008) Rüdiger Eming et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1
- (2008) E.H. Niks et al. JOURNAL OF NEUROIMMUNOLOGY
- Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients
- (2008) Isabel Illa et al. JOURNAL OF NEUROIMMUNOLOGY
- Isolation of Pathogenic Monoclonal Anti-Desmoglein 1 Human Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies
- (2007) Ken Ishii et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now